Advanced SearchSearch Tips
Development of an aequorin-based assay for the screening of corticotropin-releasing factor receptor antagonists
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Development of an aequorin-based assay for the screening of corticotropin-releasing factor receptor antagonists
Noh, Hyojin; Lee, Sunghou;
  PDF(new window)
Corticotropin-releasing factor(CRF), one of the stress driven neuropeptides, was widely proposed to influence hair loss and re-growth. For the development of receptor antagonists, the screening system based on intracellular calcium signal process was developed and optimized. The aequorin parental cells were transfected with CRF1 receptor and alpha 16 promiscuous G protein cDNA to establish HEK293a16/hCRF1, a stable cell line for the human CRF1 receptor. In HEK293a16/hCRF1 cells, the range of sauvagine dose response was 12-fold higher() than in the transiently expressed cells, hence essential conditions for the antagonist screening experiments such as the robust signals and high solvent tolerance were secured. The standard antagonists for the CRF1 receptor, antalarmin and CP154526, resulted values of and , respectively. Similar results were presented with frozen HEK293a16/hCRF1 cells. Finally, our HEK293a16/hCRF1 cells with the aequorin based cellular functional assay can be a model system for the development of functional cosmetics and modulators that can have a clinical efficacy on hair re-growth.
Drug screening;Corticotropin releasing factor receptor;G-protein coupled receptor;High throughput screening;
 Cited by
최적의 luminescence 신호 분석을 위한 유전자 전달 방법의 비교연구,박서현;이승호;

한국산학기술학회논문지, 2016. vol.17. 11, pp.640-647 crossref(new window)
Lucas, M., Chen, A., Richter-Levin, G. "Hypothalamic corticotropin-releasing factor is centrally involved in learning under moderate stress.", Neuropsychopharmacology, 38(9), 1825-1832, 2013. DOI: crossref(new window)

Arborelius, L., Owens, M.J., Plotsky, P.M., Nemeroff, C. B. "The role of corticotropin-releasing factor in depression and anxiety disorders.", J Endocrinol, 160(1), 1-12, 1999. DOI: crossref(new window)

Dong, H., Murphy, K.M., Meng, L., Montalvo-Ortiz, J., Zeng, Z., Kolber, B.J., Zhang, S., Muglia, L.J., Csernansky, J.G. "Corticotrophin releasing factor accelerates neuropathology and cognitive decline in a mouse model of Alzheimer's disease.", J Alzheimers Dis, 28(3), 579-592, 2012. crossref(new window)

Hillhouse, E.W., Randeva, H., Ladds, G., Grammatopoulos, D. "Corticotropin-releasing hormone receptors.", Biochem Soc Trans, 30(4), 428-432, 2002. DOI: crossref(new window)

Muramatsu, Y., Suqino, N., Suzuki, T., Totsune, K., Takahashi, K., Tashiro, A., Hongo, M., Oki, Y., Sasano, H. "Urocortin and corticotropin-releasing factor receptor expression in normal cycling human ovaries.", J Clin Endocrinol Metab, 86(3), 1362-1369, 2001. DOI:

Hemley, C.F., McCluskey, A., Keller, P.A. "Corticotropin releasing hormone-a GPCR drug target.", Curr Drug Targets, 8(1), 105-115, 2007. DOI: crossref(new window)

Dautzenberg, F.M., Kilpatrick, G.J., Hauger, R. L., Moreau, J. "Molecular biology of the CRH receptors in the mood.", Peptides, 22(5), 753-760, 2001. DOI: crossref(new window)

Karteris, E., Grammatopoulos, D., Randeva, H., Hillhouse, E.W. "Signal transduction characteristics of the corticotropin-releasing hormone receptors in the feto-placental unit." J Clin Endocrinol Metab, 85, 1989 -1996, 2000. DOI: crossref(new window)

Grammatopoulos, D.K., Randeva, H.S., Levine, M. A., Katsanou, E.S., Hillhouse, E.W. "Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1a and R2b CRH receptor subtypes and stimulation of Gq-proteins.", Mol Endocrinol, 14, 2076 -2091, 2000. DOI:

Kasahara, M., Groenink, L., Olivier, B., Sarnyai, Z. "Corticotropin-releasing factor (CRF) over-expression down-regulates hippocampal dopamine receptor protein expression and CREB activation in mice.", Neuro Endocrinol Lett, 32(2), 193-198, 2011.

Budziszewska, B., Zajac, A., Basta-Kaim, A., Leskiewicz, M., Steczkowska, M., Lason, W., Kacinski, M. "Effects of neurosteroids on the human corticotropin-releasing hormone gene.", Pharmacol Rep, 62(6), 1030-1040, 2010. DOI: crossref(new window)

Wang, L., Million, M., Rivier, J., Rivier, C., Craft, N, Stenzel-Poore, M.P., Tache, Y. "CRF receptor antagonist astressin-B reverses and prevents alopecia in CRF over-expressing mice.", PLoS One, 6(2), e16377, 2011. DOI: crossref(new window)

Fang, Y. "Ligand-receptor interaction platforms and their applications for drug discovery", Expert Opin Drug Discov, 7, 969-988, 2012. DOI: crossref(new window)

Lee, S., "Platform technologies for research on the G protein coupled receptor: Applications to drug discovery research", Biomol Therapeutics, 19, 1-8, 2011. DOI: crossref(new window)

Peters, M.F., Vaillancourt, F., Heroux, M., Valiquette, M. and Scott, C.W. "Comparing label-free biosensors for pharmacological screening with cell-based functional assays", Assay & Drug Develop Tech, 8, 219-227, 2010. DOI: crossref(new window)

Button, D., Brownstein, M. "Aequorin- expressing mammalian cell line used to report Ca2+ mobilization.", Cell Calcium, 14(9):663-671, 1993. DOI: crossref(new window)

Eglen, R.M. and Reisine, T. "Photoproteins: Important new tools in drug discovery", Assay & Drug Develop Tech, 6, 659-671, 2008. DOI: crossref(new window)

Inouye, S., Noguchi, M., Sakaki, Y., Takagi, Y., Miyata, T., Iwanaga, S. and Tsuji, F.I. "Cloning and sequence analysis of cdna for the luminescent protein aequorin", Proc Natl Acad Sci U S A, 82, 3154-3158, 1985. DOI: crossref(new window)

Prasher, D., McCann, R.O. and Cormier, M.J. "Cloning and expression of the cdna coding for aequorin, a bioluminescent calcium-binding protein", Biochem Biophys Res Commun, 126, 1259-1268, 1985. DOI: crossref(new window)

Dupriez, V.J., Maes, K., Le Poul, E., Burgeon, E. and Detheux, M. "Aequorin-based functional assays for g-protein-coupled receptors, ion channels, and tyrosine kinase receptors", Receptors Channels, 8, 319-330, 2002. DOI: crossref(new window)

Ueda, T., Ugawa, S., Ishida, Y., Hondoh, A. and Shimada, S. "Development of generic calcium imaging assay for monitoring gi-coupled receptors and g-protein interaction", J Biomol Screen, 14, 781-788, 2009. DOI: crossref(new window)

Noh, H., Lee, S. "Optimization of the cryopreserved condition for utilization of GPCR frozen cells", J Korea Acad Cooper Soc, 16(2), 1200-1206, 2015. DOI:

Dautzenberg, F.M., Gutknecht, E., Van der Linden, I., Olivares-Reyes, J.A., Durrenberger, F. and Hauger, R.L. "Cell-type specific calcium signaling by corticotropinreleasing factor type 1 (crf1) and 2a (crf2(a)) receptors: Phospholipase c-mediated responses in human embryonic kidney 293 but not sk-n-mc neuroblastoma cells", Biochem Pharmacol, 68, 1833-1844, 2004. DOI: crossref(new window)

Huang, H.J. and Chen, C.Y. "A possible solution for hair loss by inhibiting corticotropin-releasing factor (crf) receptor from traditional chinese medicine", J Biomol Str & Dynamics, 32, 1613-1623, 2014. DOI: crossref(new window)

Zhang, J.H., Chung, T.D., Oldenburg, K.R. "A simple statistical parameter for use in evaluation and validation of high throughput screening assays", J Biomol Screen, 4, 67-73, 1999. DOI: crossref(new window)